News Johnson & Johnson Deutsche Boerse AG

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 07:29:15 31/05/2024 pm IST			5-day change	1st Jan Change
134 ^EUR	-0.14%		-1.09%	-5.41%

03:42pm	J&J: completes acquisition of Shockwave Medical	CF
03:33pm	Johnson & Johnson Closes Acquisition of Shockwave Medical	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J&J: completes acquisition of Shockwave Medical	07:12pm	CF
Johnson & Johnson Closes Acquisition of Shockwave Medical	07:03pm	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	06:16pm	BU
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30/05	MT
Johnson & Johnson : to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) Press Release	30/05	PU
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	29/05
J&J: encouraging results in the treatment of depression	29/05	CF
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	29/05	MT
J&J's treatment for depression succeeds in late stage study	29/05	RE
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	29/05	CI
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
Sector Update: Health Care Stocks Fall Late Afternoon	29/05	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28/05	MT
Sector Update: Health Care	28/05	MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	28/05	MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	28/05	MT
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	28/05	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05	MT
Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion	28/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST